Conley Chee - President & CEO, Director at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Conley Chee since 7/14/2023

Holdings reported by Conley Chee for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 22.5 K $115 K $5.12 Apr 1, 2024 Direct
Restricted Stock Units 23.3 K $103 K $4.42 Mar 31, 2024 Direct Common Stock

Transactions reported by Conley Chee for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership